HistoSonics, the developer of the Edison® Histotripsy System and novel histotripsy therapy platform, today announced a management-led majority stake acquisition […] The post HistoSonics Announces $2.25B Acquisition by Consortium of Top-Tier Investors appeared first on HistoSonics .